Placebo ( FE)

DRUG3 trials

Sponsors

Changchun Intellicrown Pharmaceutical Co. LTD, University of Rostock, The Christ Hospital

Conditions

Angina With Non-Obstructive Coronary Artery DiseaseChronic Subdural HematomasCoronary Microvascular Dysfunction (CMD)Nonalcoholic Steatohepatitis (NASH)

Phase 1

To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in Healthy Subjects

RecruitingNCT06216041

Changchun Intellicrown Pharmaceutical Co. LTDNonalcoholic Steatohepatitis (NASH)

Start: 2023-12-06End: 2025-08-01Target: 138Updated: 2025-04-11

Phase 2

Prospective Clinical Investigation on Infection as a Cause of Chronic Subdural Hematoma.

RecruitingNCT07556991

University of RostockChronic Subdural Hematomas

Start: 2024-09-01End: 2027-06-30Target: 164Updated: 2026-04-29

aDAPt-ANOCA: Dapagliflozin for the Treatment of Angina With Non-Obstructive Coronary Artery Disease (ANOCA)

Not yet recruitingNCT07741890

The Christ HospitalAngina With Non-Obstructive Coronary Artery Disease, Coronary Microvascular Dysfunction (CMD)

Start: 2026-09-01End: 2029-03-01Target: 120Updated: 2026-08-03